Curcumin have various health-beneficial properties in numerous studies. However, its bioavailability is low due to its limited intestinal uptake and rapid metabolism. This study aimed to evaluate the pharmacokinetics of newly developed sub-micron particle curcumin with increased water dispersibility (Theracurmin® CR-033P). Plasma curcumin levels were measured at 0, 1, 2, 4, 8 h after Theracurmin® CR-033P intake using high-performance liquid chromatography. For analyzing pharmacokinetics of Theracurmin® CR-033P, eighteen healthy subjects were recruited and received Theracurmin® CR-033P at a single oral dose containing curcumin 30 mg. Cmax was 28.14 ng/ml, and the area under the curve for 8 h was estimated to be 104.36 ng/ml. Based on the area under the plasma concentration (AUC), the bioavailability of sub-micron particle curcumin was higher 22-, 35-, 28-fold than native curcumin in men, women, and all subjects, respectively. For comparing by formulation, seven healthy subjects were recruited and received two type of treatment: (1) existing dosage form 300 mg (contained curcumin 30 mg) × 3 capsule, (2) high dosage form 300 mg (contained curcumin 90 mg) × 1 capsule + placebo 300 mg × 2 capsule. In the cross-over study, there was no significant differences in Cmax and AUC of plasma curcumin. In conclusion, submicron particle curcumin with increased water dispersibility significantly improved its oral bioavailability and women absorbed curcumin more effectively than men. Different formulation of Theracurmin® CR-033P has shown equivalent to the reference in terms of pharmacokinetics.

To enhance the oral bioavailability (BA) of curcumin (CUR), we applied 1 wt% CUR-loaded lipid nanoparticle (LNP) system prepared with tristearin (TS) and short (Brij S10) / long (Brij S100) PEGylated surfactants. All LNPs were colloidally stable under high ion strength and pH 3 conditions regardless of the PEG chain length. However, the long-chained PEGylation prevented LNP surface better than the short-chained PEGylation from the lipase/bile salt adsorption according to ζ potential results after treatment of lipase and bile solutions. Actually, the short-chained LNPs were digested rapider than the long-chained one in the simulated small intestinal condition due to the faster displacement of PEGylated surfactants on LNP surface by bile salts. Furthermore in the rat model pharmacokinetics for oral administration of CUR, the long-chained LNP group had 10.62-fold BA of native CUR group due to the coabsorption of CUR with the mixed micelles made after gastrointestinal digestion, and had 4.57-fold BA of the short-chained LNP group despite the same molarity use (17.058 mM) of both emulsifiers due to the reduced digestion rate by long-chained PEG on LNP surface. In conclusion, since CUR incorporated in LNPs was improved in the bioavailability, the designed LNP system may serve as an encapsulation strategy to enhance the bioavailability of non-bioavailable nutraceuticals in foods.

Toxicity test of contaminate soil is very complex because of differential bioavailability in the soil. Therefore, bioavailability of metals in soil is a major factor influencing estimates of toxicity. In this study, the two major test was conducted. First, the toxicity of arsenic for the Collembola, Paronychiurus kimi, was assessed by determining the effects of increasing arsenic concentration on survival, reproduction and body concentration of As in five forested soils with different available phosphate and oxide-metal concentration. Second, the sequential extraction procedure (SEP) for arsenic by choosing extraction reagents commonly used for sequential extraction of metals was tested. The EC50 based on total As concentration in soil was estimated respectively. The available phosphate and oxide-metal concentration in soil influenced on As fraction in soil. Especially, As in soil which is non specifically and specifically sorbed (fraction 1, 2) has strong correlation with available phosphate and oxide-metal concentration (p<0.05). The toxicity is more higher in the soil with high available phosphate and low oxide-metal concentration. In addition, the high arsenic concentration in fraction which is amorphous and poor-crystalline hydrous oxide of Fe and Al (fraction 3) had effect to the toxicity. As a result, the toxicity of As is related with As concentration in fraction 1, 2 and 3 and the soil properties and the arsenic fractionation in soil have a influence on the bioavailability and toxicity.

Copper is an essential micronutrient whose deficiency is often seen to occur in humans. Although many biomedical studies have focused on the use of nanoparticles, the nutritional effects of nano-sized copper oxide particles are not well known. This aim of this study was to investigate the nutritional bioavailability of nano- and micro-sized copper oxide (CuO) particles in copper-deficient (CuD) mice. Copper deficiency was induced in mice by feeding a CuD diet (0.93 mg Cu/kg diet) for 7 weeks. After the induction of copper deficiency, nano- or micro-sized copper oxide particles were administered orally at two different doses (0.8 and 4.0 mg CuO/kg body weight) to mice in the following groups: (1) normal control (NC), (2) CuD, (3) low dose micro-sized CuO, (4) high dose micro-sized CuO, (5) low dose nano-sized CuO, and (6) high dose nano-sized CuO. The hepatic copper concentration in the CuD group was significantly lower than that in the NC group. Compared to the NC group, the CuD group exhibited lower serum ceruloplasmin (CP) activity and CP level. The copper/zinc-superoxide dismutase activity in the CuD group was significantly lower than that in the NC group. Treatment with nano- or micro-sized copper oxide particles for 2 weeks restored the hepatic copper levels and serum CP activities to values similar to those observed in the NC group. The CP levels and copper/zinc-superoxide dismutase activities in all the copper oxide treatment groups also recovered to normal values after 3 weeks of copper oxide treatment. These results show that oral administration of either nano- or micro-sized copper oxide particles for 2–3 weeks restored the normal condition in previously CuD mice.

Iron nanoparticles (Fe-NPs) have recently been used for cancer diagnosis and therapy for imaging contrast and drug delivery. However, no study on nutritional bioavailability of Fe-NPs in the body has been reported. Ascorbic acid (AA) is known to aid in absorption of iron in the stomach by reducing Fe (III) to Fe (II). In this study, we investigated the bioavailability of Fe-NPs with AA in iron-deficiency-anemic mice in comparison with non-nano iron particles. Iron-deficient anemia was induced by feeding an iron-deficient diet (4.5 mg Fe/kg) and ocular bleeding from retro-orbital venous plexus for four weeks. Normal control mice were given a normal diet (45 mg Fe/ kg). After induction of anemia in mice, anemic mice received daily oral administration of Fe (40 mg/kg B.W.) + AA (5 g/kg B.W) and Fe-NPs (40 mg/kg B.W) + AA (5 g/kg B.W). After sacrifice, liver and spleen tissues were observed by haematoxylin & eosin stain. Amount of trace iron in liver and upper small intestine was investigated using an inductively coupled plasma-atomic emission spectrometer. Red blood cells (RBC), hematocrit (Hct), hemoglobin (Hb), and total iron binding capacity were also measured. The concentrations of iron in the Fe-NPs + AA group were significantly higher in liver and in upper small intestine than that in the Fe + AA group. The values of RBC, Hct, and Hb in the Fe-NPs + AA group were more rapidly increased to normal values compared with the Fe + AA group with increasing time. These results suggest that Fe-NPs in the presence of AA may be more bioavailable than non-nano Fe in Fe-deficient anemic mice.

Benthic organisms dwell in sediment-water interface that contains significant amount of organic and inorganic contaminants. Their feeding behavior is highly related with sediment itself and pore water in the sediments, especially in ease of deposit feeder

Background : Angelica gigas is a biennial or short lived perennial plant found in China, Japan, and Korea. The root of Angelica gigas has been used in oriental traditional medicine and is marketed as a functional food product in Europe and North America. Cham-Dang-Gui (Korean Angelica, the dried root of Angelica gigas Nakai (AGN)) has been principally cultivated in Korea and used as a Korean medicinal herb. It contains several chemicals, such as pyranocoumarins, essential oils, and polyacetylenes. Methods and Results : Fresh Angelica gigas Nakai was purchased from Pyeongchang (Korea). Standard samples of D, DA were obtained from Korea Promotion Institute for Traditional Medicine Industry (Gyeongsan, Korea). Soluplus was purchased from BASF (Ludwigshafen, Germany). AGN was dried in the oven at 55°C for 24 h and cooled at room temperature. The AGN sample was then stored at 4°C until milling. Oral solid formulations based on Angelica gigas Nakai and Soluplus were prepared by the hot melt extrusion (HME) method. AGN was pulverized into coarse and ultrafine particles, and their particle size and morphology were investigated. Ultrafine AGN particles were used in the HME process with high shear to produce AGN-based formulations. In simulated gastrointestinal fluids (pH 1.2 and pH 6.8) and water, significantly higher amounts of the major active components of AGN, decursin (D) and decursinol angelate (DA), were extracted from the HME-processed AGN/Soluplus group than the AGN EtOH extract group (p < 0.05). Based on an in vivo pharmacokinetic study in rats, the relative oral bioavailability of decursinol (DOH), a hepatic metabolite of D and DA, in administered mice was 8.75-fold higher than in AGN EtOH ext-treated group. Conclusion : Soluplus-included solid formulation prepared by HME can be a promising carrier for oral delivery of phytochemicals. These findings suggest that HME-processed AGN/Soluplus formulation could be a promising therapeutic candidate for oral bioavailability.

Background : Indigenous plant in Jeju island, Sasa quelpaertensis Nakai, belongs to the Bambusoideae and inhabit around Mt. Halla. According to the ancient book such as Dongui Bogam, Sasa quelpaertensis Nakai have been known to possess the antidiabetic, anti-inflammatory, and anti-diuresis effect. However, because of gradual upturning temperature, Sasa quelpaertensis Nakai was spread out to wider area and intrude the habitat that other plant species are growing. Recently, although the study to seek effective use of Sasa quelpaertensis Nakai, the investigation about functional properties has not been taken place enough. Methods and Results : To assess the inhibitory activity of melanin synthesis, we employ the tyrosine as substrate and measure the formation of dopaquione at 490 nm. Firstly, 0.1 mM potassium phosphate buffer and tyrosinase were mixed and incubated at 37℃. After incubating at 37℃, the absorbance rate was measured at 490 nm. The value was compared with positive control, arbutin, and calculated with the rate between sample and control value. Previously, formononetin, glabrene, glabridin, glabrol, artocarbene, dihydromoriin are known as effective substances for whitening. Moreover, the arbutin, which was separated from Arctostaphylos uva-ursi (L.) Sprengel, are widely used in cosmetic field. Arbutin inhibits tyrosinase and tyrosine synthesis, which induce blackish pigmentation. Practically, the Sasa quelpaertensis Nakai leaf ethanol extract depend on different solvent condition, whole extracts showed stronger inhibition than arbutin. Especially, 60% ethanol extract exhibited twice higher tyrosinase inhibitory activity than arbutin, whereas least inhibitory activity was seen in 20% ethanol extract. Conclusion : In this study, a attempt was made to investigate the tyrosinase inhibitory activity of Sasa quelpaertensis Nakai leaves extracted by different solvent condition. In the results, each extracts was prior to arbutin. Yet, 20% ethanol extract was lowest, but on the one hand, 60% ethanol extract demonstrated the highest tyrosinase inhibitory activity.